Showing results (2061-2070 of 5,261) with videos related to

Sort By:
Pageof 527
Oncology|July 16, 2005
Prospective, double-blind, placebo-controlled, multicenter, randomized phase III study with orally administered budesonide for prevention of irinotecan (CPT-11)-induced diarrhea in patients with advanced colorectal cancerM Karthaus, Harald Ballo, Wolgang Abenhardt, et al.
Oncology|July 16, 2005
Weekly docetaxel in pretreated metastatic breast cancer patients: a phase I-II studyCecilia Nisticò, Francesco Cognetti, Luciano Frontini, et al.
Oncology|July 16, 2005
Maintenance hormone therapy with letrozole after first-line chemotherapy for advanced breast cancerGianfilippo Bertelli, Ornella Garrone, Laura Bertolotti, et al.
Oncology|July 16, 2005
Biweekly docetaxel-irinotecan treatment with filgrastim support is highly active in antracycline-Paclitaxel-refractory breast cancer patientsGiuseppe Frasci, Giuseppe D'Aiuto, Renato Thomas, et al.
Oncology|July 16, 2005
Loss of growth hormone secretagogue receptor 1a and overexpression of type 1b receptor transcripts in human adrenocortical tumorsLuisa Barzon, Monia Pacenti, Giulia Masi, et al.
Oncology|July 16, 2005
Phase II randomized study comparing the toxicity profile of gemcitabine plus cisplatin with gemcitabine plus oral etoposide in the treatment of advanced non-small cell lung cancerTony S K Mok, Kwok Chi Lam, Conrad Lee, et al.
Oncology|April 2, 2005
Association of regular aspirin use and breast cancer riskHelen Swede, Amy L Mirand, Ravi J Menezes, et al.
Oncology|July 15, 2005
The role of 5-fluorouracil (5-FU) reintroduction with irinotecan or oxaliplatin in truly 5-FU-refractory advanced colorectal cancer patientsM Scartozzi, A Sobrero, G Gasparini, et al.
Oncology|July 15, 2005
Weekly dose-dense cisplatin-epirubicin-paclitaxel administration with granulocyte colony-stimulating factor support does not substantially improve prognosis in extensive disease small-cell lung cancer. A SICOG phase II studyGiuseppe Frasci, Pasquale Comella, Ignazio Carreca, et al.
Oncology|July 15, 2005
Clinical significance of nuclear morphometry at the invasive front of T1 colorectal cancer and relation to expression of VEGF-A and VEGF-CMotohiro Kojima, Akira Shiokawa, Nobuyuki Ohike, et al.
Pageof 527